- Release Date: 07/04/22 09:45
- Summary: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
- Price Sensitive: No
- Download Document 453.01KB
- Forums
- ASX - By Stock
- EMD
- Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
EMD
emyria limited
Add to My Watchlist
7.32%
!
4.4¢

Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.4¢ |
Change
0.003(7.32%) |
Mkt cap ! $25.06M |
Open | High | Low | Value | Volume |
4.2¢ | 4.6¢ | 4.2¢ | $107.3K | 2.467M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 38760 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1905 | 0.046 |
2 | 70000 | 0.043 |
4 | 265559 | 0.042 |
2 | 111708 | 0.041 |
4 | 675000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 17605 | 1 |
0.050 | 230414 | 4 |
0.052 | 37074 | 2 |
0.054 | 24000 | 1 |
0.060 | 24999 | 2 |
Last trade - 10.20am 29/07/2025 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |